RecruitingNCT05377957

Prospective Registration Of Patient Data and Quality of Life in Eye Melanoma Patients

Sponsor

Leiden University Medical Center

Enrollment

500 participants

Start Date

Mar 5, 2019

Study Type

OBSERVATIONAL

Conditions

Uveal Melanoma

Summary

PROQEM is a prospective cohort study among patients diagnosed with uveal melanoma to assess quality of life before and in the first five years after treatment.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting information and tracking quality of life in patients with melanoma of the eye (specifically the choroid or ciliary body, the inner layers at the back of the eye) to better understand how treatments affect outcomes over time. **You may be eligible if...** - You are 18 or older - You have been diagnosed with melanoma of the choroid or ciliary body (a type of eye cancer) - Your cancer has not spread to other parts of your body - You are being treated with brachytherapy (radiation seeds), proton therapy, or eye removal (enucleation) **You may NOT be eligible if...** - There are no exclusion criteria for this study — all qualifying patients are welcome Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERQuality of life questionnaires

Collection of patient-reported outcomes concerning general and health-related quality of life and impact of uveal melanoma diagnosis

OTHERDiscrete choice experiment

Assessment of patient preferences for outcomes of proton therapy and enucleation

OTHERShared decision-making analysis

Assessment of shared decision-making from the perspective of the patient (by questionnaire), physician (by questionnaire) and a neutral observer (by audiotape), combined with patient-reported satisfaction and regret of the treatment decision (by questionnaire)

OTHERImpact of side-effects analysis

Assessment of the impact of side-effects by questionnaire